Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,273,814
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
24,855,592
-
Shares change
-
+3,514,563
-
Total reported value, excl. options
-
$453,129,001
-
Value change
-
+$68,036,540
-
Number of buys
-
73
-
Number of sells
-
-22
-
Price
-
$18.22
Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q1 2021
106 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q1 2021.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,855,592 shares
of 126,273,814 outstanding shares and own 19.68% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,995,638 shares), BlackRock Inc. (2,290,580 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2,010,348 shares), VANGUARD GROUP INC (1,541,731 shares), PURA VIDA INVESTMENTS, LLC (1,507,552 shares), Avidity Partners Management LP (1,463,403 shares), EMERALD MUTUAL FUND ADVISERS TRUST (1,401,953 shares), Nuveen Asset Management, LLC (966,215 shares), Assenagon Asset Management S.A. (902,705 shares), and GEODE CAPITAL MANAGEMENT, LLC (730,112 shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.